Select News Items featuring Valcreate
Zee Business | Rajesh Pherwani | June 26, 2026
The sharp fall in crude oil prices has brought markets back to where they were before the Iran conflict..
Business Today | Rajesh Pherwani | April 26, 2026
Days after semaglutide, the molecule behind blockbuster weight-loss drugs, went off patent in India, prices dropped sharply as multiple generic versions entered the market.
Money Control | Rajesh Pherwani | November 18, 2024
Valcreate Lifesciences & Specialty strategy was amongst the top-10 out-performers during the month of Oct-24 despite a weak market sentiment.
Money Control | Rajesh Pherwani | August 14, 2024
According to data from PMS Bazaar, Valcreate Investment Managers - Lifesciences and Specialty Opportunity Fund ranked first, with a return of 12.13 percent in July.